Optic IconOptic Logo
|
SearchCollectionsBenchmarks
Clinical trial

Treatment Outcome With Antibiotic Use and Its Resistance Pattern Among Patient With Neonatal Sepsis

ID
Name
neonatal sepsis treatment
Description
Determine Treatment outcome with antibiotic use and its resistance pattern among neonatal sepsis patients
Trial arms
Trial start
2023-03-31
Estimated PCD
2024-12-01
Trial end
2024-12-31
Status
Not yet recruiting
Treatment
Antibiotic
role of antibiotics in treatment of neonatal sepsis
Size
100
Primary endpoint
Sepsis convelence
24hours
Sepsis convelence
1 week
Eligibility criteria
Inclusion Criteria: * Newborn suspected with sepsis diagnosed on the basis of clinical signs and symptoms: * temperature instability * feeding problems, * convulsions, * lethargy * respiratory distress. * laboratory findings such as: * C-Reactive Protein (CRP) * complete blood count (CBC) * blood/urine cultures Exclusion Criteria: * Respiratory distress syndrome * Congenital pneumonia
Protocol
{'studyType': 'OBSERVATIONAL', 'patientRegistry': False, 'designInfo': {'observationalModel': 'COHORT', 'timePerspective': 'PROSPECTIVE'}, 'enrollmentInfo': {'count': 100, 'type': 'ESTIMATED'}}
Updated at
2023-02-24

1 organization

1 product

1 indication

Organization
Assiut University
Product
Antibiotic
Indication
Neonatal Sepsis